BRPI0519647A2 - métodos para tratar um paciente mamìfero tendo inflamação de tecido oral, e para reduzir a inflamação do tecido oral em um paciente mamìfero - Google Patents

métodos para tratar um paciente mamìfero tendo inflamação de tecido oral, e para reduzir a inflamação do tecido oral em um paciente mamìfero

Info

Publication number
BRPI0519647A2
BRPI0519647A2 BRPI0519647-7A BRPI0519647A BRPI0519647A2 BR PI0519647 A2 BRPI0519647 A2 BR PI0519647A2 BR PI0519647 A BRPI0519647 A BR PI0519647A BR PI0519647 A2 BRPI0519647 A2 BR PI0519647A2
Authority
BR
Brazil
Prior art keywords
oral tissue
inflammation
mammalian patient
tissue inflammation
treating
Prior art date
Application number
BRPI0519647-7A
Other languages
English (en)
Inventor
Abdul Gaffar
Dale Scherl
Susan M Herles
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of BRPI0519647A2 publication Critical patent/BRPI0519647A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A61K36/575—Magnolia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

MéTODOS PARA TRATAR UM PACIENTE MAMìFERO TENDO INFLAMAçãO DE TECIDO ORAL, E PARA REDUZIR A INFLAMAçãO DO TECIDO ORAL EM UM PACIENTE MAMìFERO. Método para o tratamento de um mamífero tendo inflamação do tecido oral é provido, em que o tecido oral inflamado é colocado em contato com uma composição oral não-irritante, eficaz, segura, tendo um agente anti-inflamatório que compreende um extrato de magnólia. O ingrediente ativo anti-inflamatório de magnólia reduz um ou mais mediadores de inflamação e reduz a inflamação no tecido oral. A composição oral pode estar sob a forma de uma solução de enxaguadura bucal; dentifrício, incluindo pastas de dente, géis, pós, pastilhas, gel medicamentoso; produtos animais; e os similares.
BRPI0519647-7A 2004-12-29 2005-12-21 métodos para tratar um paciente mamìfero tendo inflamação de tecido oral, e para reduzir a inflamação do tecido oral em um paciente mamìfero BRPI0519647A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64016104P 2004-12-29 2004-12-29
US11/285,809 US20060140885A1 (en) 2004-12-29 2005-11-23 Method of reducing oral tissue inflammation using magnolia extract
PCT/US2005/046238 WO2006071653A1 (en) 2004-12-29 2005-12-21 Method of reducing oral tissue inflammation using magnolia extract

Publications (1)

Publication Number Publication Date
BRPI0519647A2 true BRPI0519647A2 (pt) 2009-07-14

Family

ID=36181071

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519647-7A BRPI0519647A2 (pt) 2004-12-29 2005-12-21 métodos para tratar um paciente mamìfero tendo inflamação de tecido oral, e para reduzir a inflamação do tecido oral em um paciente mamìfero

Country Status (11)

Country Link
US (1) US20060140885A1 (pt)
EP (1) EP1835925A1 (pt)
AR (1) AR052854A1 (pt)
AU (1) AU2005322191B2 (pt)
BR (1) BRPI0519647A2 (pt)
CA (1) CA2591845A1 (pt)
MX (1) MX2007008079A (pt)
MY (1) MY144292A (pt)
RU (1) RU2406522C2 (pt)
TW (1) TW200637569A (pt)
WO (1) WO2006071653A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060140881A1 (en) * 2004-12-22 2006-06-29 Guofeng Xu Oral care compositions containing flavonoids and flavans
US7592025B2 (en) * 2005-12-02 2009-09-22 Gic Innovations Company Vehicles for oral care with magnolia bark extract
US20070140990A1 (en) 2005-12-21 2007-06-21 Nataly Fetissova Oral Compositions Comprising Propolis
US20100055218A1 (en) * 2006-07-14 2010-03-04 Daniel Raederstorff Novel compositions
WO2008006582A1 (en) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases
US9682256B2 (en) * 2006-07-14 2017-06-20 Colgate-Palmolive Company Methods of making compositions comprising films
EP2455134B1 (en) 2007-04-19 2016-05-11 Mary Kay, Inc. Magnolia extract containing compositions
EP2070524A1 (en) * 2007-12-11 2009-06-17 DSM IP Assets B.V. Compositions comprising Magnolol and/or Honokiol and glucosamine and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
EP2070523B1 (en) * 2007-12-11 2010-08-18 DSM IP Assets B.V. Composition comprising Magnolol and Honokiol in synergistic amount
EP2070525A1 (en) * 2007-12-11 2009-06-17 DSM IP Assets B.V. Compositions comprising Magnolol and/or Honokiol and chondroitin and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
PL2288346T3 (pl) * 2008-05-30 2014-06-30 Wrigley W M Jun Co Kompozycje doustne zawierające skojarzenia przeciwutleniaczy i wyciągów z magnolii o zwiększonej skuteczności przeciwbakteryjnej
KR20090128725A (ko) * 2008-06-11 2009-12-16 한국생명공학연구원 일본 후박나무 추출물 또는 이의 분획물을 유효성분으로함유하는 염증성 질환 예방 및 치료용 조성물
US20100130622A1 (en) * 2008-11-21 2010-05-27 Kazuo Nagai Pharmaceutical preparation for preventing and/or treating periodontal disease, agent for oral hygiene comprising thereof, and food comprising thereof
TWI459957B (zh) 2010-02-24 2014-11-11 美國棕欖公司 口腔保健組成物
TWI422382B (zh) 2010-02-24 2014-01-11 Colgate Palmolive Co 加強木蘭活性物之溶解度及傳送的組成物
ES2507615T3 (es) 2010-02-25 2014-10-15 Colgate-Palmolive Company Síntesis de magnolol y sus compuestos análogos
JP5675178B2 (ja) * 2010-06-09 2015-02-25 大島　光宏 コラーゲン分解阻害剤
MY161382A (en) 2010-07-29 2017-04-14 Colgate Palmolive Co Phosphate free oral care compositions based on magnolia antibacterial agent
RU2580642C2 (ru) * 2011-01-31 2016-04-10 Колгейт-Палмолив Компани Композиции для ухода за полостью рта
HK1215162A1 (zh) * 2012-12-06 2016-08-19 Colgate-Palmolive Company 用於敏感性和牙齿疼痛的口用凝胶
MX345485B (es) * 2012-12-07 2017-01-31 Lozoya Legorreta Xavier Composiciones equibióticas y métodos para el tratamiento de enfermedad periodontal y/o halitosis en animales.
US10292917B2 (en) 2012-12-21 2019-05-21 Colgate-Palmolive Company Oral care composition
US9433644B2 (en) 2013-07-25 2016-09-06 Rutgilli Pharmaceuticals, Llc Formulations and methods for treating oral inflammation, injury, or pain
JP2015007054A (ja) * 2014-07-24 2015-01-15 コルゲート・パーモリブ・カンパニーＣｏｌｇａｔｅ−Ｐａｌｍｏｌｉｖｅ Ｃｏｍｐａｎｙ マグノロールおよびその類似体化合物の合成
RU2599026C1 (ru) * 2015-09-04 2016-10-10 федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) Состав для заживления тканей полости рта
AU2016321396B2 (en) * 2015-09-11 2021-12-23 Wm. Wrigley Jr. Company Synergistic antibacterial effects of magnolia bark extract and L-arginine, N-alpha-lauroyl ethyl ester on plaque biofilm
AU2016321383B2 (en) * 2015-09-11 2021-12-23 Wm. Wrigley Jr. Company Synergistic antibacterial effects of magnolia bark extract and L-arginine, N-alpha-lauroyl ethyl ester on salivary bacteria
US20210378926A1 (en) * 2018-10-24 2021-12-09 Conopco, Inc., D/B/A Unilever A topical composition
CN113242751B (zh) 2018-12-18 2023-09-19 联合利华知识产权控股有限公司 抗微生物组合物
US11857655B2 (en) 2018-12-21 2024-01-02 Conopco. Inc. Antimicrobial compositions comprising modified clay and nonionic triblock copolymers
CN118831070A (zh) * 2024-08-07 2024-10-25 安徽中医药大学 一种促进线粒体自噬的靶向纳米制剂及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454164A (en) * 1982-01-22 1984-06-12 Nabisco Brands, Inc. Soft canine biscuit containing discrete meat and/or meat by-product particles and method for making same
US4454163A (en) * 1982-01-22 1984-06-12 Nabisco Brands, Inc. Canine biscuit containing discrete meat and/or meat by-product particles and method for making same
US4443430A (en) * 1982-11-16 1984-04-17 Ethicon, Inc. Synthetic absorbable hemostatic agent
US5000943A (en) * 1989-05-30 1991-03-19 Nabisco Brands, Inc. Canine biscuits containing an inorganic pyrophosphate
US5180577A (en) * 1990-10-09 1993-01-19 Colgate-Palmolive Stabilized bis biguanide/anionic active ingredient compositions
US5405836A (en) * 1993-03-02 1995-04-11 Nabisco, Inc. Pet foods with water-soluble zinc compound coating for controlling malodorous breath
RU2080855C1 (ru) * 1994-04-12 1997-06-10 Акционерное общество закрытого типа "Химико-биологическое объединение при РАН" Средство для лечения и профилактики заболеваний полости рта
KR0176015B1 (ko) * 1996-03-26 1999-03-20 서치영 치주질환 예방 및 치료제 조성물
US20030206874A1 (en) * 1996-11-21 2003-11-06 The Proctor & Gamble Company Promoting whole body health
WO2001082922A1 (en) * 2000-04-27 2001-11-08 The Procter & Gamble Company Oral compositions comprising polyphenol herbal extracts
US6290933B1 (en) * 2000-05-09 2001-09-18 Colgate-Palmolive Company High cleaning dentifrice
US6500409B1 (en) * 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
US6685921B2 (en) * 2000-10-25 2004-02-03 The Procter & Gamble Company Dental care compositions
AU2003279301B2 (en) * 2002-06-25 2008-04-24 Wm. Wrigley Jr. Company Breath freshening and oral cleansing product with Magnolia bark extract

Also Published As

Publication number Publication date
AU2005322191A1 (en) 2006-07-06
US20060140885A1 (en) 2006-06-29
WO2006071653A1 (en) 2006-07-06
AU2005322191B2 (en) 2009-08-20
TW200637569A (en) 2006-11-01
RU2007128940A (ru) 2009-02-10
MY144292A (en) 2011-08-29
MX2007008079A (es) 2007-07-13
AR052854A1 (es) 2007-04-04
CA2591845A1 (en) 2006-07-06
RU2406522C2 (ru) 2010-12-20
EP1835925A1 (en) 2007-09-26

Similar Documents

Publication Publication Date Title
BRPI0519647A2 (pt) métodos para tratar um paciente mamìfero tendo inflamação de tecido oral, e para reduzir a inflamação do tecido oral em um paciente mamìfero
US8784852B2 (en) Topical skin care composition
ES2751671T3 (es) Composición cosmética calmante basada en ácido salicílico
US8580317B2 (en) Compositions and methods for treating acne
PT1227820E (pt) Acidos oligossacarido-aldonicos e sua utilizacao topica
BRPI0507727A (pt) composições para cuidado da pele
BRPI0318498B1 (pt) composições terapêuticas à base de porifera para o tratamento e a prevenção de doenças da pele
ES2420516T3 (es) Composiciones tópicas y uso de las mismas para el tratamiento de afecciones relacionadas con el epitelio
KR100673044B1 (ko) 경피 투여용 국소 조성물
CN101500525A (zh) 用于治疗痤疮和用于逆转老化征兆与太阳伤害的药物及使用这种药物的方法
DE60136475D1 (de) Therapeutische topische hautlösung und relevante anwendungsmethoden
ES2127613T3 (es) Utilizacion de un antagonista de tnf-alfa para el tratamiento de rojeces cutaneas de origen neurogeno.
US10071052B2 (en) Method for the prevention and treatment of acne
PE20001567A1 (es) Composicion de resorcinol
US7438937B2 (en) Topical burn composition containing Mentha haplocalyx and one or both of Aloe vera and recombinant human epidermal growth factor
CO2023011644A2 (es) Composición antitranspirante
JP2016501236A (ja) 炎症性皮膚状態の予防および治療のための方法
Morganti et al. Activity of Chitin Nanofibrils block-copolymers entrapping Zn/Al/SA/Allantoin on Seborrheic Dermatitis. A randomized double-blind placebo controlled study
ES2645535T3 (es) Composiciones tópicas para tratar trastornos, enfermedades y dolencias inflamatorios
KR20240137862A (ko) 제니스테인을 함유하는 여드름 예방 및 치료용 화장료
Dharmik et al. Anti-Acne Activity of Toothpaste–An Emerging Pimple Treatment
ES2562985B1 (es) Composición farmacéutica para el tratamiento de lesiones de la piel
IT202100011750A1 (it) Formulazione per acne rosacea
Ayala et al. COS DERM
Ikeno et al. COS DERM

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO EM SUA FORMA AUTENTICADA; OU SEGUNDO PARECER DA PROCURADORIA, DEVE CONSTAR UMA DECLARACAO DE VERACIDADE, A QUAL DEVE SER ASSINADA POR UMA PESSOA DEVIDAMENTE AUTORIZADA A REPRESENTAR O INTERESSADO, DEVENDO, PORTANTO CONSTAR NO INSTRUMENTO DE PROCURACAO, OU NO SEU SUBSTABELECIMENTO.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 7A. ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2203 DE 26/03/2013.